Abstract
Conclusions
DBI by mouth produces an improvement in glucose tolerance in patients with severe as well as mild diabetes mellitus. It appears to be an active potent hypoglycemic agent, effective in patients with mild, moderate and severe diabetes mellitus. The results herein presented lend encouragement to wider experimental and clinical investigations.
Get full access to this article
View all access options for this article.